Skip to product information
1 of 1

Nature's Bounty CoQ10 200mg Dietary Supplement - 30 Capsules

Nature's Bounty CoQ10 200mg Dietary Supplement - 30 Capsules

Brand ownership disclosureFOR SALE — May 2026
Nestlé Health Science (divestment underway)
Nestlé S.A. (SIX: NESN)
Acquired 2021 via $5.75B Bountiful deal. Now for sale as of May 2026 — new owner expected within 6-18 months.
Read reviews →
Also see: Amazon · Google · Reddit
Regular price $31.32 USD
Regular price Sale price $31.32 USD
Sale Sold out
Shipping calculated at checkout.
Quantity

The full picture

Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →

65/100
Standard

Six-dimension breakdown

Evidence
68
Formulation
65
Manufacturing
68
Safety
75
Transparency
62
Sustainability
58

Why this scored 65/100

Nature's Bounty is a mainstream US supplement brand owned by Bountiful Company with mass-retail distribution. This SKU is a single-ingredient CoQ10 at a disclosed 200 mg per capsule dose taken once daily. CoQ10 has one of the stronger cardiovascular-health evidence bases in the supplement category: the Q-SYMBIO trial (Mortensen 2014) showed CoQ10 300 mg/day reduced major cardiovascular events in chronic heart failure patients, and multiple meta-analyses support use in statin-associated myalgia (Fedacko 2013, Banach 2015). 200 mg is a reasonable daily dose — the studied range is 100-400 mg with mid-range trials at 200 mg showing measurable serum-level increases. Ubiquinone (oxidized) vs ubiquinol (reduced) form matters somewhat — ubiquinol has 2-3x better bioavailability in older adults — but Nature's Bounty typically uses ubiquinone which is fine for most users. Standard-tier entry. USP verification and disclosed form (ubiquinone vs ubiquinol) would push toward Verified.

Last scored: Full rubric →

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.

How to read the Evidence dimension

  • 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
  • 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
  • 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
  • 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
  • 0–19: No credible evidence base or unverifiable claims.

FAQ data has not been generated for this product yet. See the site FAQ for general questions.

Customer reviews

Reviews on other platforms

The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.

All the data we have on this product

Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.

VSF score
65 / 100
Tier
Standard
Category
Supplements
Subcategory
cardiovascular heart
Last scored
Third-party certifications
None on record at time of scoring
Vendor
Beauty Care Bag
Product type
Supplements
Tags
Beauty Care Bag, Shopify Collective

Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.

View full details